GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer.

The tumor suppressor gene PTEN (phosphatase and tensin homolog deleted on chromosome 10) plays important roles in tumor development and progression. Among many functions, PTEN negatively regulates the AKT anti-apoptotic signaling pathway, while nuclear PTEN affects the cell cycle by repressing the mitogen-activated protein kinase pathway. However, the regulation of PTEN expression is still not well understood. We previously reported that androgen receptor (AR) activates PTEN transcription in breast cancer cells. Here, we found that the transcription factor GATA2 (GATA binding protein 2) is overexpressed in non-cultured human breast carcinomas and is negatively correlated with PTEN expression. We then showed GATA2 promotes breast cancer cell growth and stimulates AKT phosphorylation by inhibiting PTEN transcription. We mapped a GATA2-binding site in the PTEN promoter, whereby GATA2 not only blocks AR-induced PTEN expression by preventing AR nuclear translocation, but also directly represses PTEN transcription independent of AR. Most importantly, for the first time, we have discovered a novel reverse regulation within the traditional PTEN/AKT signaling pathway, whereby AKT induces GATA2 with consequent decreased PTEN transcription, likely germane in tumor invasion and metastases but not initiation.

[1]  R. Silverman,et al.  Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers , 2011, Oncogene.

[2]  Reid F. Thompson,et al.  DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis , 2011, Mammalian Genome.

[3]  C. Eng,et al.  Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. , 2011, Cancer letters.

[4]  R. Silverman,et al.  Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines , 2010, Human molecular genetics.

[5]  O. Feron,et al.  The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism , 2010, Oncogene.

[6]  J. Kench,et al.  A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes , 2009, Oncogene.

[7]  Brian J. Wilson,et al.  GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis , 2009, Oncogene.

[8]  M. Shakibaei,et al.  Resveratrol addiction: to die or not to die. , 2009, Molecular nutrition & food research.

[9]  Y. Wang,et al.  Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival , 2008, Oncogene.

[10]  Katsunobu Sakurai,et al.  Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers , 2008, International Journal of Clinical Oncology.

[11]  C. Eng,et al.  Regulation of the PTEN promoter by statins and SREBP. , 2007, Human molecular genetics.

[12]  Y. Wang,et al.  A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells , 2007, Oncogene.

[13]  Matthias Frisch,et al.  Androgen receptor binding sites identified by a GREF_GATA model. , 2005, Journal of molecular biology.

[14]  C. Eng,et al.  Phytoestrogen exposure elevates PTEN levels. , 2005, Human molecular genetics.

[15]  M. Federici,et al.  Phosphorylation of GATA2 by Akt Increases Adipose Tissue Differentiation and Reduces Adipose Tissue–Related Inflammation: A Novel Pathway Linking Obesity to Atherosclerosis , 2005, Circulation.

[16]  D. Troyer,et al.  Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. , 2005, Endocrine-related cancer.

[17]  Paul E Swanson,et al.  Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. , 2003, American journal of clinical pathology.

[18]  Charis Eng,et al.  PTEN: One Gene, Many Syndromes , 2003, Human mutation.

[19]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[20]  M. Rosenfeld,et al.  Reciprocal Interactions of Pit1 and GATA2 Mediate Signaling Gradient–Induced Determination of Pituitary Cell Types , 1999, Cell.

[21]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[22]  S. Orkin,et al.  GATA-binding transcription factors in hematopoietic cells. , 1992, Blood.

[23]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.